IRVINE, Calif., Oct. 9, 2007 (PRIME NEWSWIRE) -- "There's no doubt that the tide is turning to healthier beverages," stated SmallCap Sentinel analyst D.R. Clark. "Whether it's the removal of sugary soft drinks from the school setting or the popularity of leaner and cleaner alternatives, what once looked like fad is clearly beverage trend. Move into this wave of interest specialty beverages targeting the enormous population of diabetics and perhaps it becomes more clear why Sweet Success (OTCBB:SWTS) is ramping up production and dramatically increasing distribution."
A comprehensive report focusing on beverage maker Sweet Success Enterprises, and of interest to investors in Hansen Natural Corporation (Nasdaq:HANS), The Coca Cola Company (NYSE:KO), and PepsiCo (NYSE:PEP) has been published by financial courier StockUpTicks.com and is available free of charge to the investing public at http://stockupticks.com/profiles/5-2-07.html
"Last night's after-market release by Sweet Success affirms a pattern of continued increase in production, this time announcing that the company will ramp production to fulfill delivery to over 90 new pharmacies in need of its popular GlucaSafe(tm) beverage, which was developed to maintain healthy glucose levels, lower hypertension and cholesterol," Clark noted. "I find two elements of this news particularly intriguing. First, that pharmacies are purchasing the beverage...not just retail stores looking for churn on their shelves, and secondly, that the company is successfully penetrating well beyond the Texas locations where they first found traction. These 90+ pharmacies are all northern."
San Antonio-based Sweet Success Enterprises, Inc. acquired Nestle's original Sweet Success(tm) brand in 2002 and has re-launched a product line to tap into the rapidly growing demand for convenient and nutritious functional beverages.
To have your company featured on StockUpTicks.com or SmallCap Sentinel please use the contact info below.
The SmallCap Sentinel logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3664
For more D.R. Clark views on the market visit www.ClarkReport.com
These statements have not been evaluated by the FDA. Sweet Success products are not intended to diagnose, treat, cure or prevent disease.
Statements herein contain forward-looking statements and are subject to significant risks and uncertainties affecting results. SmallCap Sentinel/StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect proposed actions and cannot project capabilities, intent, resources, or experience.
All information contained herein is based upon sources believed to be reliable but no representation is made as to accuracy or completeness. This report is neither a solicitation to buy nor an offer to sell securities but is rather a paid advertisement provided for information purposes only and should not be used as the basis for any investment decision. MP isn't an investment advisor and this report isn't investment advice. MP has been paid 325,000 restricted shares by Sweet Success for preparation/distribution of this report and other advertising services over a six-month period. This constitutes a conflict of interest as to MP's ability to remain objective in communication regarding the subject company.
CONTACT: Market Pathways/StockUpTicks Kurt Divich, Editor 702-396-1000